Ajay K. Wakhloo, MD, PhD, FAHA is an internationally renowned tenured Professor of Radiology, Neurology and Neurosurgery and the Director, Division NeuroImaging and Intervention (NII) in the Department of Radiology, University of Massachusetts Medical School. Prior to moving to Massachusetts, Dr. Wakhloo was a tenured Professor of Radiology, Neurological Surgery and Biomedical Engineering in the Department of Radiology at the University of Miami, Miller School of Medicine. He received his medical degree from the University of Mainz, Germany, where he also received his Ph.D. He completed his Internship and Residency in Internal Medicine at the University of Mainz, and continued his training in Radiology at the University of Freiburg, Germany. He conducted a Fellowships in Neurosurgery (University of Freiburg) and Endovascular Neurosurgery (SUNY-Buffalo), as well as Research Fellowships in Neurological Surgery (Barrow Neurological Institute) and in Neurosurgery (SUNY-Buffalo).
Dr. Wakhloo has been the principal investigator or co-investigator on numerous grants from the National Institutes of Health (NIH), American Heart Association (AHA), private foundations and industry. He has over 500 publications, presentations and abstracts, including 2 books on stroke treatment, and more than 250 peer reviewed articles and book chapters. He has been the recipient of numerous scientific awards and honors, among others Whitaker Bioengineering Research Foundation Award, German Society of Neuroradiology and Society of Vascular Interventional Neurology Innovation Award. He was named a Fellow of the American Heart Association and the Stroke Council in 2009. He holds several US patents for neurovascular devices.
Dr. Wakhloo pioneered the field of flow diversion, the newest technology for the minimally invasive treatment of brain aneurysms. He has been the central figure in the commercial development of this technology, which is undergoing a U.S. Food and Drug Administration premarket approval clinical trial. He was also the first to introduce and publish the concept of using a stent to remove an embolus for the treatment of stroke which is currently the standard endovascular treatment for acute ischemic stroke. He has been a founder and has served as CEO and CMO of various medical device companies.
Dr. Wakhloo has served on numerous Editorial Boards and is a reviewer for more than 15 Medical Journals, is currently a consulting editor for Stroke and has served in wide capacity on several national and international professional societies. He is a member of the Medical Advisory Boards for several Pharmaceutical and Device companies. He has consistently held positions of university and departmental services. He has, throughout his career, been dedicated to teaching and mentoring faculty, fellows and residents from various disciplines as well as supervising doctoral students and serving as a research adviser to individuals throughout their research careers.
Dr. Wakhloo is a member of key societies in the field of cerebrovascular disorders (AANS, CNS, IEEE, ASNR, SNIS, ASSR, AHA, RSNA, ARRS) and he is a Fellow of the International Academy of Clinical and Applied Thrombosis/Homeostasis. His primary areas of focus include acute stroke therapy, isolation of intracranial aneurysms and arteriovenous malformations.
At this stage in his career, Dr. Wakhloo takes great pride and satisfaction in teaching the future leaders in neurointerventional surgery and is currently with his colleges, developing technologies in the field of cerebrovascular and soft tissue disorders.